학술논문
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
Document Type
Article
Author
Paolella, Brenton R.; Gibson, William J.; Urbanski, Laura M.; Alberta, John A.; Zack, Travis I.; Bandopadhayay, Pratiti; Nichols, Caitlin A.; Agarwalla, Pankaj K.; Brown, Meredith S.; Lamothe, Rebecca; Yong Yu; Choi, Peter S.; Obeng, Esther A.; Heckl, Dirk; Guo Wei; Wang, Belinda; Tsherniak, Aviad; Vazquez, Francisca; Weir, Barbara A.; Root, David E.
Source
Subject
*CANCER cells
*CELL lines
*DNA copy number variations
*SPLICEOSOMES
*CELL death
*
*
*
*
Language
ISSN
2050-084X
Abstract
Genomic instability is a hallmark of human cancer, and results in widespread somatic copy number alterations. We used a genome-scale shRNA viability screen in human cancer cell lines to systematically identify genes that are essential in the context of particular copy-number alterations (copy-number associated gene dependencies). The most enriched class of copy-number associated gene dependencies was CYCLOPS (Copy-number alterations Yielding Cancer Liabilities Owing to Partial losS) genes, and spliceosome components were the most prevalent. One of these, the pre-mRNA splicing factor SF3B1, is also frequently mutated in cancer. We validated SF3B1 as a CYCLOPS gene and found that human cancer cells harboring partial SF3B1 copy-loss lack a reservoir of SF3b complex that protects cells with normal SF3B1 copy number from cell death upon partial SF3B1 suppression. These data provide a catalog of copy-number associated gene dependencies and identify partial copy-loss of wild-type SF3B1 as a novel, non-driver cancer gene dependency. [ABSTRACT FROM AUTHOR]